Teleflex (NYSE:TFX) Announces Earnings Results

Teleflex (NYSE:TFX) issued its quarterly earnings data on Thursday. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03, Zacks reports. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Price Performance

Shares of NYSE:TFX traded down $38.64 during trading on Thursday, hitting $138.99. 3,336,604 shares of the stock were exchanged, compared to its average volume of 612,600. The company has a market cap of $6.46 billion, a PE ratio of 27.63, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex has a 12-month low of $135.95 and a 12-month high of $249.90. The company has a fifty day moving average price of $177.07 and a two-hundred day moving average price of $206.17. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. Teleflex’s dividend payout ratio is presently 27.04%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on TFX shares. Truist Financial lowered their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.